awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33428259-4E63F93D-93C7-43E1-8BC4-DAC7726E13C2
Q33428259-4E63F93D-93C7-43E1-8BC4-DAC7726E13C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33428259-4E63F93D-93C7-43E1-8BC4-DAC7726E13C2
Practical management of myelofibrosis with ruxolitinib.
P2860
Q33428259-4E63F93D-93C7-43E1-8BC4-DAC7726E13C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33428259-4E63F93D-93C7-43E1-8BC4-DAC7726E13C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5cbbaeaebed19cb4988ef9871dce50a2e032a51c
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.